Skip to main content
Clinical Trials/NCT01361230
NCT01361230
Completed
N/A

PILOT STUDY: A Randomized Controlled Trial of Intensive Care Management of Sedation Using Patient Responsiveness in Critical Care IMPROVE Critical Care Study Pilot

GE Healthcare1 site in 1 country74 target enrollmentDecember 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sedated ICU Patients
Sponsor
GE Healthcare
Enrollment
74
Locations
1
Primary Endpoint
Proportion of time spent with low responsiveness (red colour code) during the first 48 hours in the ICU
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The Pilot Clinical Investigation planned is a prospective, unblinded randomized pilot trial comparing sedation management using a protocol based on responsiveness with standard sedation management. The hypothesis is that responsiveness will improve a range of patient-based and economic outcomes, including the duration of mechanical ventilation and duration of coma in the ICU. The purpose of the pilot study is to gather information for designing a full study that might show the validity of the outcome hypothesis.

Registry
clinicaltrials.gov
Start Date
December 2009
End Date
May 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients mechanically ventilated via an endotracheal tube and receiving intravenous sedation with a hypnotic agent (midazolam or other benzodiazepine) or propofol by continuous infusion.

Exclusion Criteria

  • Primary intracerebral disorder (includes cardiac arrest with probable hypoxic brain injury; intrac-ranial haemorrhage; head injury causing reduced conscious level prior to intubation)
  • Patient who is already awake at the time of enrolment defined as RASS ³ -1
  • Age \<16 years
  • Patient not expected to survive the next 24 hours
  • Patient receiving long term ventilation prior to ICU admission
  • Patient with a long term tracheostomy prior to ICU admission
  • Patient transferred sedated and mechanically ventilated from another ICU unless recruitment is possible within 24 hours of first ICU admission
  • Patient receiving continuous neuromuscular blocking agent at the time of screening for enrolment
  • Previously enrolled in the trial during a separate ICU admission during this hospital stay
  • Status epilepticus

Outcomes

Primary Outcomes

Proportion of time spent with low responsiveness (red colour code) during the first 48 hours in the ICU

Time Frame: 8 month period

The main purpose in the statistical analysis is not to test the statistical significance of the differences but to provide descriptive statistics for the full outcome study plan.

Secondary Outcomes

  • Proportion of time spent with RASS score -4/-5 during the first 48 hours in the ICU.(8 months)

Study Sites (1)

Loading locations...

Similar Trials